Publication | Closed Access

METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-κB to promote the malignant progression of IDH-wildtype glioma

Tumor BiologyGliomaMedicineM6a ModificationCancer Cell BiologyMalignant ProgressionIdh-wildtype GliomaRadiation OncologyCancer BiologyCell BiologyCancer ResearchCancer Growth